Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

8.94
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
5.00
Today|||52-Week Range
9.25
+50.25%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close8.94
Today’s open8.94
Day’s range8.81 - 8.94
Volume2,842
Average volume (3 months)11,585
Market cap$45.2M
Data as of 3:59pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio894.0
Price/Sales2.70
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.02-2.62%
APVOAptevo Therapeutics ...-0.09-2.26%
BPTHBio Path Holdings In...+0.00+1.32%
CSBRChampions Oncology I...+0.15+3.78%
Data as of 4:00pm ET, 12/12/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts